FormWeb • ganciclovir

IHS FormWeb

Approved Formulary

Staff Telephone Numbers

Webpage Links

Add Formweb to your mobile device

Android iOS

Search results for:

ganciclovir

ganciclovir

Brand names: Cytovene

Form	Strength
POWDER FOR INJECTION, INTRAVENOUS	500 mg

Display Nucleosides and Nucleotides Class: 081832

Medication comments:

USP <800> Hazardous Drug Assessment of Risk (AOR)
Per policy, these drugs are exempt from USP <800> handling requirements under normal circumstances. The following outlines must be followed.
generic (Brand) Route [Packaging: Manufacturer ⇒ Dispense]		NIOSH Group
ganciclovir (Cytovene) IV [n/a]		Non - Antineoplastic
Pharmacy: Receiving / Storage / Preparation Exposure Risk: medium	• Handling/preparation PPE Requirements: Double CX gloves , gown , CSTD
	• Receiving from Distributor: Standard
	• Pharmacy Storage Area: Chemo
	• Packaging/Reconstitution Location: n/a
	• Compounding (Non-Sterile/Sterile) Location: Ideal: Negative pressure room- CACI Required: Med Prep Area with Immediate Use Preparation standards
	• Omnicell Load: No
Transport	• Transport (dose is placed inside a plastic sealable bag): Transport container, single CX gloves
Nursing: Storage / Admin. Exposure Risk: medium	• Handling/administration PPE Requirements: Double CX gloves , gown , use of CSTD
	• Storage of Finished dose in Nursing Area/Procedural Area: Patient Med Drawer
	• Signage on Patient Door Required: Yes
	• Manipulation of Dosage Form: n/a
	• Special Manipulation for Administration: n/a
Disposal / Spills	• Disposal of Drug Waste: Full- black bin , trace- yellow bin
	• Disposol of Used PPE: yellow bin
	• Spill management: Manage like antineoplastic agents
NIOSH Supplemental Information: in animal studies - carcinogenic, tetratogenic and caused aspermatogenesis; mfg instructions - handle according to guidelines issued for antineoplastic drugs
Reason for exemption of USP<800> Containment Requirements: Preg Category C. Avoid direct contact of the skin or mucous membranes with CYTOVENE-IV solutions. If such contact occurs, wash thoroughly with soap and water; rinse eyes thoroughly with plain water.

Last updated: Apr. 4, 2024

Hazard.Drug Handling(USP 800) USP<800> Hazardous Drug / Assessment of Risk
Black Box Warnings Hematological toxicity; IV and oral different indications

Pharmacy Contact Info:

Main Inpatient Pharmacy: ext 4599, 3503
Fax: 704-878-7283

Director of Pharmacy - Randi Raynor, PharmD: ext 4501
Clinical Coordinator - Laura Rollings, PharmD: ext 4597
Pharmacy Informaticist - Stephen Pringle, PharmD: ext 7645
Pharmacy Technician Supervisor - Amy Wingler, CPhT: ext 7385
Pharmacy Automation Coordinator (Omnicell) - Melissa Fulford, CPhT: ext 3556

This site is intended for the staff of Iredell Memorial Hospital.
While others may view accessible pages, Iredell Memorial Hospital makes no warranty, express or implied,
as to the use of this information outside of Iredell Memorial Hospital.
The content of this policy and procedure document serves as guidance to the delivery of quality patient care.
Care providers are expected to exercise critical thinking and situational awareness skills,
and in specific situations to take such action as is necessary for the delivery of quality patient care.